Author： Cook Daniel M.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.32, Iss.11, 2009-11, pp. : 1057-1066
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
The impact of Black Box Warnings
Reactions Weekly, Vol. 1, Iss. 1358, 2011-01 ,pp. :
Black-box warning messages differ between FDA, lay media
Reactions Weekly, Vol. 1, Iss. 1282, 2009-01 ,pp. :
The US FDA `Black Box' Warning for Topical Calcineurin Inhibitors: An Ongoing Controversy
Drug Safety, Vol. 31, Iss. 3, 2008-01 ,pp. :
US FDA strengthens isotretinoin risk management programme
Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. :